Advancing Dermatology: How AI Is Shifting from Diagnosis to Comprehensive Workflow Support

      Artificial intelligence (AI) has rapidly progressed within the medical field, with dermatology often highlighted as a prime candidate for its application due to its inherently visual nature. However, early AI developments in dermatology predominantly focused on sophisticated diagnostic algorithms, often overlooking the broader spectrum of clinical and administrative challenges faced by practitioners. A recent nationwide survey in India, detailed in an academic paper from July 2026, sheds light on this disparity, revealing that dermatologists are increasingly turning to general-purpose AI tools to enhance daily practice, particularly for workflow management and information synthesis, rather than specialized image analysis (Sengupta et al., 2026). This shift underscores a critical need for a "problem-first" approach in AI development, ensuring technology truly addresses the most pressing clinical needs.

The Evolution of AI in Dermatology: Beyond the "Diagnostic Oracle"

      For years, the narrative surrounding AI in dermatology has been heavily weighted towards its ability to interpret visual data, such as distinguishing between benign lesions and malignant melanomas. This "technology-push" model, driven by what AI, particularly convolutional neural networks (CNNs), can do, has yielded impressive results in controlled, experimental settings, often achieving diagnostic accuracies comparable to human experts. These AI systems excel at tasks like binary classification, offering significant potential in early skin cancer detection. However, the successful integration of these advanced diagnostic tools into the everyday flow of clinical practice remains a hurdle. The emphasis on AI as a "diagnostic oracle" has often overshadowed its potential to address other substantial burdens in dermatology, including administrative tasks, patient education, and long-term disease management.

      A systematic review published in Dermato in 2025 further corroborates AI's strong performance in diagnostic accuracy for conditions like melanoma, noting improvements in workflow efficiency and access to specialized care. The review highlighted that AI tools could achieve up to 90% accuracy in melanoma detection and significantly reduce mismanagement of malignant lesions from 58.8% to 4.1% in certain scenarios. While these diagnostic capabilities are transformative, the practical adoption often hinges on how well AI integrates into existing clinical routines and solves immediate, tangible problems (Martínez-Vargas et al., 2025).

Addressing Core Workflow Bottlenecks

      The Indian survey, conducted with 377 dermatologists, specifically adopted a "problem-first" methodology, first identifying clinical frustrations before evaluating AI usage. This approach revealed that chronic disease management presents more frequent challenges than diagnostic uncertainty. For instance, patient adherence to treatment plans (61.3% of respondents) and developing effective treatment strategies for difficult or refractory cases (57.0%) were reported as significant pain points, compared to diagnostic uncertainty (48.0%). This indicates that while diagnostic accuracy is important, the day-to-day complexities of managing ongoing conditions often consume more clinical time and resources.

      A notable example of workflow struggle was observed in the management of atopic dermatitis (AD), a common chronic inflammatory skin disease. Objective severity scoring systems, such as EASI (Eczema Area and Severity Index) and SCORAD (Scoring Atopic Dermatitis), are crucial for tracking disease progression and treatment efficacy. However, nearly half of the dermatologists (47.7%) reported challenges with these scoring methods, which also had the lowest satisfaction rate among all measured workflow areas. These systems can be time-consuming and subjective, leading to inconsistencies in patient assessment. This highlights an opportunity for AI to provide clinician-supervised workflow support, perhaps by automating aspects of severity scoring or streamlining data collection. For organizations looking to implement such systems, a provider like ARSA Technology offers Custom AI Solutions that can be tailored to address specific operational inefficiencies in healthcare.

The Practical Application of General-Purpose AI

      Interestingly, despite the specialized nature of dermatological diagnostics, the survey found that approximately half (49.9%) of respondents were already adopting AI, primarily through general Large Language Models (LLMs). These tools were not typically used for intricate image analysis but for more generalized administrative and academic tasks, such as summarizing research papers, drafting clinical notes, or preparing academic content. This suggests that dermatologists are finding immediate value in AI's ability to streamline information processing and documentation, thereby freeing up valuable time.

      Barriers to AI adoption varied with experience. Veteran dermatologists (those with over 20 years of practice) frequently cited a lack of adequate training (64.3%) as a primary impediment. In contrast, junior dermatologists (with five or fewer years of experience) were more likely to report a lack of perceived clinical utility after initially trying AI tools (22.8%). These findings emphasize the need for AI solutions that are not only intuitive and easy to learn but also demonstrate clear, measurable benefits in real-world clinical scenarios. Solutions that offer flexible deployment, like AI Video Analytics Software, can provide on-premise processing, minimizing data transfer concerns and ensuring robust, reliable operation for image-based tasks, even if not directly for LLM usage.

Navigating Ethical Concerns and Future Directions

      The survey also brought to light significant ethical and practical concerns among AI users. Dermatologists actively using AI were more likely to express apprehension regarding patient self-misdiagnosis and associated anxiety. This concern was independently linked to active AI usage, even after accounting for clinical experience and academic affiliation. There was also heightened concern among AI users about the potential misuse of these technologies by non-dermatologists. These concerns underscore the importance of clear guidelines and clinician oversight in the deployment of AI in healthcare, particularly when tools are accessible directly to patients.

      These findings advocate for a future where AI tools are developed to support, rather than replace, clinical judgment. Rather than standalone diagnostic "oracles," future AI in dermatology could be more effective as clinician-supervised workflow support systems. This includes applications that assist with the complex and longitudinal aspects of chronic disease management, refine objective severity scoring, and automate administrative burdens. Such tools could help ensure data privacy and control, aligning with compliance requirements—an area where platforms providing secure, on-premise data handling are essential. For instance, advanced face recognition systems, like the Face Recognition & Liveness SDK, offer robust identity verification within a secure, self-hosted environment, which could be relevant for patient identity management or secure access to medical records. Furthermore, self-service health solutions, such as ARSA Technology’s Self-Check Health Kiosk, demonstrate how AI can facilitate patient data collection in a controlled, supervised manner, enhancing workflow without compromising diagnostic integrity.

      The integration of AI in dermatology must therefore prioritize human-centered design, addressing practical clinical needs and ethical considerations head-on. By focusing on workflow augmentation and clinician supervision, AI can move beyond its initial diagnostic capabilities to become an invaluable partner in delivering more efficient, consistent, and patient-centric dermatological care. This shift promises not only improved operational efficiency for clinics and hospitals but also better outcomes for patients grappling with chronic conditions.

Sources

Sengupta, D., Panda, S., Dhar, S., De, D., Pandhi, D., & Narayanan, B. (2026). How Indian Dermatologists are Utilizing Artificial Intelligence for Clinical Practice and Workflow Management: A Nationwide Survey with a Special Focus on atopic dermatitis*. arXiv preprint arXiv:2607.01252. Martínez-Vargas, E., Mora-Jiménez, J., Arguedas-Chacón, S., Hernández-López, J., & Zavaleta-Monestel, E. (2025). The Emerging Role of Artificial Intelligence in Dermatology: A Systematic Review of Its Clinical Applications. Dermato, 5*(2), 9. https://doi.org/10.3390/dermato5020009

      Ready to transform your clinical workflows with intelligent AI and IoT solutions? Explore how ARSA Technology helps healthcare providers enhance operational efficiency, improve patient management, and streamline administrative tasks with practical, production-ready AI. Contact ARSA today to discuss your specific needs.